STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Cencora, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for proposed sale of securities. The filing reports an intended sale of 5,097 common shares through Fidelity Brokerage Services on 09/18/2025 with an aggregate market value of $1,478,130.00. The document shows total shares outstanding of 193,877,881. Acquisition details list 1,334 shares from restricted stock vesting on 09/30/2023 recorded as compensation, and 3,763 shares from options (granted 11/13/2019) transacted 09/18/2025 for cash. The filing also discloses three prior sales by Robert P. Mauch on 06/18/2025, 07/18/2025 and 08/18/2025 of ~4,968–4,969 shares each with gross proceeds shown. Several identifying fields for the filer and issuer are not provided in the text.

Positive

  • Transaction details disclosed: The filing provides specific share counts, dates, broker, and gross proceeds for recent sales.
  • Acquisition history provided: Origins of the shares (restricted stock vesting and option-related) and nature of payment are stated.

Negative

  • Missing issuer and filer identification in provided text: Key fields such as issuer name and filer CIK/CCC are not present in the content supplied.
  • Repeated insider sales: Three prior monthly sales of ~4,968–4,969 shares may be viewed negatively by some investors, though materiality relative to outstanding shares appears limited.

Insights

TL;DR: Routine insider sale notice showing modest share sales and clear acquisition origins; disclosure appears complete for transaction details.

The filing records a planned sale of 5,097 common shares valued at $1,478,130 via a broker on 09/18/2025 and documents the acquisition history: restricted stock vesting (1,334 shares) and option exercise/transfer (3,763 shares). The filing also lists three prior monthly disposals by the same individual in June, July and August 2025 with gross proceeds, indicating ongoing scheduled sales rather than a single large divestiture. From a market-impact perspective, the quantities are small relative to the reported 193,877,881 shares outstanding, suggesting limited dilution or immediate market impact based solely on these numbers.

TL;DR: Disclosure follows Rule 144 format but lacks key identifying issuer/filer fields in the provided text, which raises completeness concerns.

The notice includes required transaction-level detail: class, broker, dates, amounts, provenance of shares and past three months sales with proceeds, and the signature/representation language referencing material nonpublic information. However, the provided content omits explicit issuer name and filer CIK/CCC entries as presented here, which are essential for regulatory traceability. That omission in the supplied text limits verification and cross-referencing against issuer records.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares are proposed for sale in the Form 144 for COR?

The filing shows a proposed sale of 5,097 common shares through Fidelity Brokerage Services on 09/18/2025 with an aggregate market value of $1,478,130.00.

How were the shares being sold acquired according to the filing?

The filing lists 1,334 shares from restricted stock vesting on 09/30/2023 (compensation) and 3,763 shares from options (granted 11/13/2019) with a transaction date of 09/18/2025 paid in cash.

Does the filing show recent sales by the same person?

Yes. It discloses three sales by Robert P. Mauch on 06/18/2025, 07/18/2025, and 08/18/2025 of approximately 4,968–4,969 shares each with gross proceeds listed for each sale.

What is the total number of outstanding shares reported in the Form 144?

The filing shows 193,877,881 shares outstanding.

Are there any statements about material nonpublic information in the notice?

Yes. The signature/representation language states the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

71.49B
185.78M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN